RAD's CEO and PH just finished a webinar giving an overview.
As a side note, when talking radio therapeutic molecules targeting PD and HER check point inhibitors, the CEO said that the aim is to be at the front of new approaches and that RAD is a bit ahead of its time. Maybe that applies to IMU's B-cell tech as well - ahead of its time and therefore not accepted - yet.
GLTA
Media Thread, page-14483
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.004(7.27%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.5¢ | 5.0¢ | $1.762M | 34.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 673000 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 885816 | 4 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |